Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Toxoplasma gondii | CMGC kinase, MAPK family (ERK) MAPK-1 | 0.0057 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0187 | 0.0375 | 0.1832 |
Schistosoma mansoni | biogenic amine (5HT) receptor | 0.0769 | 0.2049 | 0.2049 |
Trichomonas vaginalis | equilibrative nucleoside transporter, putative | 0.0187 | 0.0375 | 0.0375 |
Trypanosoma cruzi | DNA repair and recombination helicase protein PIF7, putative | 0.3532 | 1 | 1 |
Giardia lamblia | Rrm3p helicase | 0.3532 | 1 | 1 |
Trypanosoma cruzi | DNA repair and recombination helicase protein PIF7, putative | 0.3532 | 1 | 1 |
Entamoeba histolytica | DNA repair and recombination protein, putative | 0.3532 | 1 | 1 |
Onchocerca volvulus | Equilibrative nucleoside transporter, putative homolog | 0.0187 | 0.0375 | 0.5 |
Trichomonas vaginalis | equilibrative nucleoside transporter, putative | 0.0187 | 0.0375 | 0.0375 |
Leishmania major | PIF1 helicase-like protein, putative,DNA repair and recombination protein, mitochondrial precursor, putative | 0.3532 | 1 | 1 |
Echinococcus multilocularis | equilibrative nucleoside transporter 3 | 0.0187 | 0.0375 | 0.0375 |
Entamoeba histolytica | hypothetical protein, conserved | 0.3532 | 1 | 1 |
Trypanosoma cruzi | DNA repair and recombination helicase protein PIF6, putative | 0.3532 | 1 | 1 |
Brugia malayi | hypothetical protein | 0.0187 | 0.0375 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0769 | 0.2049 | 1 |
Echinococcus granulosus | biogenic amine 5HT receptor | 0.0769 | 0.2049 | 0.2049 |
Trichomonas vaginalis | equilibrative nucleoside transporter, putative | 0.0187 | 0.0375 | 0.0375 |
Echinococcus multilocularis | equilibrative nucleoside transporter 3 | 0.0155 | 0.0282 | 0.0282 |
Schistosoma mansoni | hypothetical protein | 0.3532 | 1 | 1 |
Echinococcus multilocularis | serotonin receptor | 0.0769 | 0.2049 | 0.2049 |
Onchocerca volvulus | Equilibrative nucleoside transporter, putative homolog | 0.0187 | 0.0375 | 0.5 |
Trypanosoma brucei | DNA repair and recombination helicase protein PIF7 | 0.3532 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0187 | 0.0375 | 0.1832 |
Giardia lamblia | Hypothetical protein | 0.0187 | 0.0375 | 0.0375 |
Leishmania major | PIF1 helicase-like protein, putative,DNA repair and recombination protein, mitochondrial precursor, putative | 0.3532 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0187 | 0.0375 | 0.1832 |
Echinococcus multilocularis | equilibrative nucleoside transporter protein | 0.0187 | 0.0375 | 0.0375 |
Trypanosoma brucei | DNA repair and recombination helicase protein PIF6 | 0.3532 | 1 | 1 |
Echinococcus granulosus | equilibrative nucleoside transporter | 0.0187 | 0.0375 | 0.0375 |
Brugia malayi | Nucleoside transporter family protein | 0.0187 | 0.0375 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0769 | 0.2049 | 1 |
Echinococcus multilocularis | ATP dependent DNA helicase PIF1 | 0.3532 | 1 | 1 |
Trichomonas vaginalis | equilibrative nucleoside transporter, putative | 0.0187 | 0.0375 | 0.0375 |
Echinococcus multilocularis | serotonin receptor | 0.0769 | 0.2049 | 0.2049 |
Echinococcus granulosus | equilibrative nucleoside transporter 3 | 0.0187 | 0.0375 | 0.0375 |
Trichomonas vaginalis | conserved hypothetical protein | 0.3532 | 1 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
MIC (functional) | > 100 ug ml-1 | Minimum inhibitory concentration against Candida albicans (ATCC 10231) in the presence of serum | ChEMBL. | No reference |
MIC (functional) | > 100 ug ml-1 | Minimum inhibitory concentration against Candida albicans (ATCC 10231) in the absence of serum. | ChEMBL. | No reference |
MIC (functional) | > 100 ug ml-1 | Minimum inhibitory concentration against Candida albicans (579a) in the presence of serum | ChEMBL. | No reference |
MIC (functional) | > 100 ug ml-1 | Minimum inhibitory concentration against Candida albicans (579a) in the absence of serum. | ChEMBL. | No reference |
MIC (functional) | > 100 ug ml-1 | Minimum inhibitory concentration against Candida albicans (CCH 442) in the presence of serum | ChEMBL. | No reference |
MIC (functional) | > 100 ug ml-1 | Minimum inhibitory concentration against Candida albicans (CCH 442) in the absence of serum. | ChEMBL. | No reference |
MIC (functional) | > 100 ug ml-1 | Minimum inhibitory concentration against Candida albicans (ATCC 38247) in the presence of serum | ChEMBL. | No reference |
MIC (functional) | > 100 ug ml-1 | Minimum inhibitory concentration against Candida albicans (ATCC 38247) in the absence of serum. | ChEMBL. | No reference |
MIC (functional) | > 100 ug ml-1 | Minimum inhibitory concentration against Candida albicans (ATCC 62376) in the presence of serum | ChEMBL. | No reference |
MIC (functional) | > 100 ug ml-1 | Minimum inhibitory concentration against Candida albicans (ATCC 62376) in the absence of serum. | ChEMBL. | No reference |
MIC (functional) | > 100 ug ml-1 | Minimum inhibitory concentration against Candida albicans (ATCC 10231) in the presence of serum | ChEMBL. | No reference |
MIC (functional) | > 100 ug ml-1 | Minimum inhibitory concentration against Candida albicans (ATCC 10231) in the absence of serum. | ChEMBL. | No reference |
MIC (functional) | > 100 ug ml-1 | Minimum inhibitory concentration against Candida albicans (579a) in the presence of serum | ChEMBL. | No reference |
MIC (functional) | > 100 ug ml-1 | Minimum inhibitory concentration against Candida albicans (579a) in the absence of serum. | ChEMBL. | No reference |
MIC (functional) | > 100 ug ml-1 | Minimum inhibitory concentration against Candida albicans (CCH 442) in the presence of serum | ChEMBL. | No reference |
MIC (functional) | > 100 ug ml-1 | Minimum inhibitory concentration against Candida albicans (CCH 442) in the absence of serum. | ChEMBL. | No reference |
MIC (functional) | > 100 ug ml-1 | Minimum inhibitory concentration against Candida albicans (ATCC 38247) in the presence of serum | ChEMBL. | No reference |
MIC (functional) | > 100 ug ml-1 | Minimum inhibitory concentration against Candida albicans (ATCC 38247) in the absence of serum. | ChEMBL. | No reference |
MIC (functional) | > 100 ug ml-1 | Minimum inhibitory concentration against Candida albicans (ATCC 62376) in the presence of serum | ChEMBL. | No reference |
MIC (functional) | > 100 ug ml-1 | Minimum inhibitory concentration against Candida albicans (ATCC 62376) in the absence of serum. | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.